In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

U3 Pharma completes €13.25mm second round

Executive Summary

U3 Pharma AG (cellular signal transduction systems) completed a second-round private placement grossing €13.25mm ($14.35mm). New investors were Atlas Venture and LCF Rothschild Venture Partners (which co-led the financing) and BioMedical Sciences Investment Fund. Returning backers were Alta Partners (which made a significant investment), BioM, and Medicis Venture Management, as well as private investors.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies